Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China ...Middle East

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial of Ensifentrine for the maintenance treatment of chronic obstructive...

Hence then, the article about nuance pharma announces clearance of ind application for ensifentrine pivotal clinical trials for copd in china was published today ( Friday 19/08/2022 - 06:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China )

Also on site :

• Texas Roadhouse & Olive Garden among restaurants mandating strict ‘one ring’ policy for diner safety
• Alec Baldwin hits back at Elon Musk for criticizing Lupita Nyong’o’s looks amid ‘The Odyssey’ casting
• 90 minutos para el infarto: todo lo que se define en la última jornada de las ligas de España, Inglaterra e Italia